Table 4. Association of baseline continuous characteristics with PROs.

	SLICC-DI	Age at enrolment	GC daily dose	Disease duration	SELENA-SLEDAI
SF-36 PCS	Coef −0.04p=0.000	Coef −0.15p=0.003	Coef −0.05p=0.004	Coef −0.06p=0.33	Coef −0.01p=0.30
SF-36 MCS	Coef −0.01p=0.1	Coef −0.11p=0.07	Coef −0.01p=0.35	Coef −0.06p=0.26	Coef .002p=0.88
FACIT	Coef −0.04p=0.000	Coef −0.08p=0.15	Coef −0.03p=0.16	Coef 0.04p=0.52	Coef −0.01p=0.61
LIT	Coef 0.02p=0.000	Coef 0.067p=0.58	Coef 0.015p=0.13	Coef −0.03p=0.29	Coef 0.006p=0.39
HADS-A	Coef 0.06p=0.03	Coef 0.03p=0.20	Coef 0.099p=0.14	Coef 0.28p=0.20	Coef −0.04p=0.45
HADS-D	Coef 0.08p=0.003	Coef 0.04p=0.10	Coef 0.05p=0.46	Coef 0.25p=0.29	Coef −0.01p=0.79

Bold values represent statistically significant values.

CoefcoefficientFACITFunctional Assessment of Chronic Illness TherapyGCglucocorticoidsHADS-AHospital Anxiety and Depression Scale for anxietyHADS-DHospital Anxiety and Depression Scale for depressionLITLupus Impact TrackerPROsPatient-Reported OutcomesSELENA-SLEDAISafety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Activity IndexSF-36 MCSShort Form 36 mental component summarySF-36 PCSShort Form 36 physical component summarySLICCSystemic Lupus International Collaborating Clinics